Author:
Britton Amadea,Roper Lauren E.,Kotton Camille N.,Hutton David W.,Fleming-Dutra Katherine E.,Godfrey Monica,Ortega-Sanchez Ismael R.,Broder Karen R.,Talbot H. Keipp,Long Sarah S.,Havers Fiona P.,Melgar Michael
Publisher
Centers for Disease Control MMWR Office
Reference18 articles.
1. Rates of medically attended RSV among US adults: a systematic review and meta-analysis.;McLaughlin;Open Forum Infect Dis,2022
2. Use of respiratory syncytial virus vaccines in older adults: recommendations of the Advisory Committee on Immunization Practices—United States, 2023.;Melgar;MMWR Morb Mortal Wkly Rep,2023
3. Food and Drug Administration. MRESVIA [Approval letter]. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2024. https://www.fda.gov/media/179015/download?attachment
4. Food and Drug Administration. MRESVIA [Package insert]. Silver Spring, MD: US Department of Health and Human Services; 2024. https://www.fda.gov/media/179005/download
5. Efficacy and safety of an mRNA-based RSV PreF vaccine in older adults.;Wilson;N Engl J Med,2023
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献